
VEGF has been proven to increase vascular permeability by inducing the formation of structural abnormalities, including fenestrations, open gaps, and clustered and fused caveolae in the endothelium. In a study by Robert et al, tumors implanted in subcutaneous (SC) tissue vs intra-cerebral (IC) tissue were examined to see if the host microvasculature determines the morphology and therefore the function of the tumor vasculature or does VEGF override all host microvascular endothelial input.10
The study revealed that when tumors were implanted in IC tissue, the microvasculature underwent a remarkable transformation in both structure (increase in endothelial gaps and fenestrations) and function (increase in permeability). Additionally, while the tumors produced similar amounts of VEGF in the 2 conditions, the expression of VEGF receptors was increased in the IC tissue.10

The authors conclude that these results indicate there is a drastic difference in neovasculature of identical tumor types when they are grown in different locations. These findings are important, as the differences in tumor vessel morphology affect tumor permeability and, therefore, anticancer drug distribution.10